All Multiple Sclerosis (MS) reports LP Information, Inc.
All LP Information, Inc. reports Life SciencesPharmaceuticalsDiseases & Conditions Multiple Sclerosis (MS)

Publisher: LP Information, Inc.
Category: Multiple Sclerosis (MS)

Multiple Sclerosis (MS) market research reports by LP Information, Inc.

(5 reports matching your criteria)

    • Global Multiple Sclerosis (MS) Drugs Market Growth 2024-2030

      Feb 15, 2024  |  Published by: LP Information, Inc.  |  USD 3,660

      Global Multiple Sclerosis (MS) Drugs Market Growth 2024-2030 According to our LPI (LP Information) latest study, the global Multiple Sclerosis (MS) Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Multiple Sclerosis (MS) Drugs is forecast to a readju ... Read More

    • Global Multiple Sclerosis Drugs Market Growth 2024-2030

      Feb 07, 2024  |  Published by: LP Information, Inc.  |  USD 3,660

      Global Multiple Sclerosis Drugs Market Growth 2024-2030 According to our LPI (LP Information) latest study, the global Multiple Sclerosis Drugs market size was valued at US$ 14290 million in 2023. With growing demand in downstream market, the Multiple Sclerosis Drugs is forecast to a readjusted size ... Read More

    • Global Multiple Sclerosis (MS) Drugs Market Growth 2023-2029

      Mar 02, 2023  |  Published by: LP Information, Inc.  |  USD 3,660

      Global Multiple Sclerosis (MS) Drugs Market Growth 2023-2029 LPI (LP Information)' newest research report, the “Multiple Sclerosis (MS) Drugs Industry Forecast” looks at past sales and reviews total world Multiple Sclerosis (MS) Drugs sales in 2022, providing a comprehensive analysis by region and m ... Read More

    • Global Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2023-2029

      Feb 09, 2023  |  Published by: LP Information, Inc.  |  USD 3,660

      Global Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2023-2029 Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, ... Read More

    • Global Stem Cell Therapy for Multiple Sclerosis Market Growth (Status and Outlook) 2023-2029

      Feb 09, 2023  |  Published by: LP Information, Inc.  |  USD 3,660

      Global Stem Cell Therapy for Multiple Sclerosis Market Growth (Status and Outlook) 2023-2029 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the ... Read More

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help

Join Alert Me Now!

Receive bi-weekly email alerts on new research

Sign Up

Find out more on our blog
Cookie Settings